Rotavirus is a leading cause of severe diarrhea and child mortality, especially in low-middle income countries. Although introduction of WHO-prequalified rotavirus vaccines into national immunization programs of more than 110 countries has substantially increased vaccination coverage, at the global level, rotavirus vaccination coverage remains low at around 50%. Further implementation of rotavirus immunization programs is expected to prevent additional pediatric deaths related to rotavirus diarrhea. New low-cost rotavirus vaccines that have received the WHO prequalification recently will augment rotavirus vaccine supply and help overcome economic barriers toward the increasing adoption of rotavirus vaccination programs.
CITATION STYLE
Muhsen, K., & Omar, M. (2023). Rotavirus. In Molecular Medical Microbiology, Third Edition (pp. 2321–2338). Elsevier. https://doi.org/10.1016/B978-0-12-818619-0.00052-6
Mendeley helps you to discover research relevant for your work.